Evaluation of Bone Mineral Density in Patients with Type 1 Gaucher Disease in Argentina

被引:1
|
作者
Larroude, M. S. [1 ,2 ]
Aguilar, G. [1 ]
Rossi, I. [1 ]
Drelichman, G. [3 ]
Fernandez Escobar, N. [3 ]
Basack, N. [3 ]
Slago, M. [4 ]
Schenone, A. [4 ]
Fynn, A. [5 ]
Cuello, M. F. [5 ]
Fernandez, R. [5 ]
Ruiz, A. [6 ]
Reichel, P. [6 ]
Guelbert, N. [7 ]
Robledo, H. [7 ]
Watman, N. [8 ]
Bolesina, M. [8 ]
Elena, G. [9 ]
Veber, S. E. [9 ]
Pujal, G. [10 ]
Galvan, G. [10 ]
Chain, J. J. [11 ]
Arizo, A. [12 ]
Bietti, J. [12 ]
Aznar, M. [13 ]
Dragosky, M. [14 ]
Marquez, M. [14 ]
Feldman, L. [15 ]
Muller, K. [15 ]
Zirone, S. [16 ]
Buchovsky, G. [17 ]
Lanza, V. [18 ]
Fernandez, I. [19 ]
Jaureguiberry, R. [20 ]
Barbieri, M. A. [21 ]
Maro, A. [21 ]
Zarate, G. [22 ]
Fernandez, G. [22 ]
Rapetti, M. [23 ]
Degano, A. [24 ]
Kantor, G. [25 ]
Albina, A. [26 ]
Alvarez Bollea, M. [27 ]
Arrocena, H. [28 ]
Bacciedoni, V. [29 ]
Del Rio, F. [29 ]
机构
[1] Ctr Diagnost E Rossi, Dept Densitometria Osea, Prudan 422, RA-1872 Buenos Aires, DF, Argentina
[2] Hosp Cesar Milstein, Dept Densitometria Osea, Buenos Aires, DF, Argentina
[3] Hosp Ninos Dr Ricardo Gutierrez, CABA, Buenos Aires, DF, Argentina
[4] Lab Neuroquim Dr NA Chamoles, Dept Hematol, Buenos Aires, DF, Argentina
[5] Hosp Ninos Sor Maria Ludovica, Dept Hematol, La Plata, Buenos Aires, Argentina
[6] Hosp CEpsi Eva Peron, Dept Hematol, Santiago Del Estero, Argentina
[7] Hosp Prov Ninos Santa Trinidad, Dept Hematol, Cordoba, Argentina
[8] Hosp Ramos Mejia, CABA, Buenos Aires, DF, Argentina
[9] Hosp Ninos Pedro de Elizalde, CABA, Buenos Aires, DF, Argentina
[10] Hosp Dr Julio C Perrando, Dept Hematol, Chaco, Argentina
[11] Hosp Nino Jesus, Dept Hematol, San Miguel De Tucuman, Argentina
[12] Hosp Iturraspe, Dept Hematol, Santa Fe, Argentina
[13] Inst Med Platense, Dept Hematol, La Plata, Buenos Aires, Argentina
[14] Hosp Oncol M Curie, Dept Hematol, Buenos Aires, DF, Argentina
[15] Clin Modelo Tandil, Buenos Aires, DF, Argentina
[16] Clin Nino Rosario, Dept Hematol, Santa Fe, Argentina
[17] Hosp Escuela Corrientes, Dept Hematol, Corrientes, Argentina
[18] Hosp Materno Infantil Mar del Plata, Buenos Aires, DF, Argentina
[19] Hosp Del Viso, Buenos Aires, DF, Argentina
[20] Hosp San Martin, Dept Hematol, La Plata, Buenos Aires, Argentina
[21] Hosp Aleman, CABA, Buenos Aires, DF, Argentina
[22] Hosp Pirovano, CABA, Buenos Aires, DF, Argentina
[23] Hosp Ninos San Justo, Buenos Aires, DF, Argentina
[24] Sanatorio Gen Sarmiento, Buenos Aires, DF, Argentina
[25] Hosp Durand, CABA, Buenos Aires, DF, Argentina
[26] Consultorio Particular, Buenos Aires, DF, Argentina
[27] Sanatorio Allende Cordoba, Dept Hematol, Cordoba, Argentina
[28] Hosp Centenario, Gualeguychu, Entre Rios, Argentina
[29] Hosp Lagomaggiore, Dept Hematol, Mendoza, Argentina
关键词
Argentina; bone mineral density; Gaucher disease; osteoporosis; PEDIATRIC OFFICIAL POSITIONS; ENZYME REPLACEMENT THERAPY; FRACTURE PREDICTION; CHILDREN; OSTEOPOROSIS; DENSITOMETRY; ADOLESCENTS; BMD;
D O I
10.1016/j.jocd.2016.07.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The purpose of this study was to evaluate the frequency of osteoporosis (OP) in patients with Gaucher disease (GD) in Argentina. GD patients from 28 centers were consecutively included from April 2012 to 2014. Bone mineral density (BMD) was determined by dual X-ray absorptiometry in the lumbar spine and the femoral neck or the total proximal femur for patients >= 20 yr of age, and by whole-body scan in the lumbar spine in patients <20 yr of age. In children, mineral density was calculated using the chronological age and Z height. OP diagnosis was determined following adult and pediatric official position of the International Society for Clinical Densitometry. A total of 116 patients were included, of which 62 (53.5%) were women. The median age was 25.8 yr. All patients received enzyme replacement therapy, with a median time of 9.4 yr. Normal BMD was found in 89 patients (76.7%), whereas low bone mass (LBM) or osteopenia was found in 15 patients (13%) and OP in 12 patients (10.3%). The analysis of the pediatric population revealed that 4 patients (9.3%) had LBM and 3 (7%) had OP (Z-score <= -2 + fractures height-adjusted by Z), whereas in the adult population (n = 73), 11 patients (15%) had LBM or osteopenia and 9 (12.3%) had OP. Bone marrow infiltration and the presence of fractures were significantly correlated with the presence of OP (p = 0.04 and <0.001, respectively). This is the first study in Argentina and in the region describing the frequency of OP or LBM in GD patients treated with imiglucerase using the official position of the International Society for Clinical Densitometry.
引用
收藏
页码:444 / 449
页数:6
相关论文
共 50 条
  • [21] Bone Mineral Density across the Lifespan in Patients with Type 1 Diabetes
    Halper-Stromberg, Eitan
    Gallo, Tyler
    Champakanath, Anagha
    Taki, Iman
    Rewers, Marian
    Snell-Bergeon, Janet
    Frohnert, Brigitte, I
    Shah, Viral N.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2020, 105 (03) : 746 - 753
  • [22] Longitudinal Evaluation of Bone Mineral Density and Body Composition in Patients With Positive Celiac Serology
    Duerksen, Donald R.
    Leslie, William D.
    JOURNAL OF CLINICAL DENSITOMETRY, 2011, 14 (04) : 478 - 483
  • [23] Evaluation of Bone Mineral Density in Children with Celiac Disease
    Taskin, Didem Gulcu
    Ata, Aysun
    IRANIAN JOURNAL OF PEDIATRICS, 2023, 33 (04)
  • [24] Fragility fractures and bone mineral density in male patients affected by type 1 and type 2 myotonic dystrophy
    Passeri, E.
    Sansone, V. A.
    Sconfienza, L. M.
    Messina, C.
    Meola, G.
    Corbetta, S.
    NEUROMUSCULAR DISORDERS, 2020, 30 (01) : 28 - 34
  • [25] In vitro osteoclastogenesis from Gaucher patients' cells correlates with bone mineral density but not with Chitotriosidase
    Bondar, C.
    Mucci, J.
    Crivaro, A.
    Ormazabal, M.
    Ceci, R.
    Oliveri, B.
    Gonzalez, D.
    Rozenfeld, P.
    BONE, 2017, 103 : 262 - 269
  • [26] Significant and continuous improvement in bone mineral density among type 1 Gaucher disease patients treated with velaglucerase alfa: 69-month experience, including dose reduction
    Elstein, Deborah
    Foldes, A. Joseph
    Zahrieh, David
    Cohn, Gabriel M.
    Djordjevic, Maja
    Brutaru, Costin
    Zimran, Ari
    BLOOD CELLS MOLECULES AND DISEASES, 2011, 47 (01) : 56 - 61
  • [27] Bone mineral density in patients with type 2 diabetes
    Sauque-Reyna, Leobardo
    Alejandra Salcedo-Parra, Maria
    Rafael Sanchez-Vargas, Pedro
    Daniel Flores-Helguera, Juan
    Badillo-Sanchez, Carmina
    Reza-Albarran, Alfredo
    Rodriguez-Moran, Martha
    Guerrero-Romero, Fernando
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2011, 63 (02): : 162 - 169
  • [28] Bone mineral density in patients with mucopolysaccharidosis type III
    Nur, Banu Guzel
    Nur, Hakan
    Mihcil, Ercan
    JOURNAL OF BONE AND MINERAL METABOLISM, 2017, 35 (03) : 338 - 343
  • [29] ANALYSIS OF BONE MINERAL DENSITY AND RELEVANT FACTORS IN PATIENTS WITH TYPE 1 DIABETES
    Duan, Peng
    Tu, Ping
    Wu, Heping
    Ding, Xun
    Liu, Jiang
    Deng, Bo
    ARCHIVES OF BIOLOGICAL SCIENCES, 2014, 66 (03) : 1091 - 1096
  • [30] Bone ultrasonometry, bone density, and turnover markers in type 1 Gaucher disease
    Fiore, CE
    Barone, R
    Pennisi, P
    Pavone, V
    Riccobene, S
    JOURNAL OF BONE AND MINERAL METABOLISM, 2002, 20 (01) : 34 - 38